We are live on ! Find out more
KLCMU

Kite Lake Capital Management (UK) Portfolio holdings

AUM $125M
1-Year Est. Return 198.01%
This Fund
S&P 500
This Quarter Est. Return
-17.13%
1 Year Est. Return
+198.01%
3 Year Est. Return
+266.95%
5 Year Est. Return
+402.58%
10 Year Est. Return
–
AUM
$62.7M
AUM Growth
+$31.1M
Cap. Flow
+$40.9M
Cap. Flow %
65.22%
Top 10 Hldgs %
100%
Holding
8
New
5
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$22.5M
2
BTU icon
Peabody Energy
BTU
+$5.12M
3
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$4.64M
4
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$3.39M
5
NAV.PRD
Navistar International Corporation Cumulative Convertible Junior Preference Stock, Series D
NAV.PRD
+$2.73M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$6.65M

Sector Composition

Rank Sector Weight
1 Healthcare 26.81%
2 Energy 3.7%
3 Consumer Discretionary 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBPO
1
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$26.7M 42.68%
247,773
+40,391
+19% +$4.64M
PACB icon
2
Pacific Biosciences
PACB
$370M
$16.8M 26.82%
+5,490,994
New +$22.5M
QGEN icon
3
CALL
Qiagen
QGEN
$8.73B
$8.02M 12.8%
+181,821
New +$7.1M
BMY.RT
4
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$5.59M 8.93%
1,472,340
+1,030,000
+233% +$3.39M
BTU icon
5
Peabody Energy
BTU
$2.9B
$2.32M 3.7%
+800,000
New +$5.12M
NAV.PRD
6
DELISTED
Navistar International Corporation Cumulative Convertible Junior Preference Stock, Series D
NAV.PRD
$2.03M 3.24%
+123,000
New +$2.73M
NAV
7
DELISTED
Navistar International
NAV
$1.15M 1.84%
+69,800
New +$2.04M
QGEN icon
8
Qiagen
QGEN
$8.73B
– –
-170,179
Closed -$6.65M

Similar funds

SWA
Strategic Wealth Advisors Scottsdale, Arizona $125M AUM
AFA
Allium Financial Advisors Lake Oswego, Oregon $125M AUM 15.61% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
WOSD
WFA of San Diego San Diego, California $125M AUM 17.62% 1-Year Est. Return
PB
Prosperity Bancshares Houston, Texas $125M AUM
CNTOF
Canandaigua National Trust of Florida Canandaigua, New York $125M AUM 19.25% 1-Year Est. Return
PWP
Ponta Wealth Partners Winter Park, Florida $124M AUM
SGFG
Silver Grove Financial Group Orchard Park, New York $124M AUM

Kite Lake Capital Management (UK)'s Q1 2020 Portfolio in Review

As of Q1 2020, Kite Lake Capital Management (UK) held 8 positions worth $62.7M, up 99% from $31.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kite Lake Capital Management (UK) deployed $40.9M of net new capital in Q1 2020, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was Pacific Biosciences: 5,490,994 shares worth $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the most notable exit was Qiagen, an estimated $6.65M sold.

  • Kite Lake Capital Management (UK)'s largest Q1 2020 buy was Pacific Biosciences: 5,490,994 shares worth $16.8M.
  • Kite Lake Capital Management (UK) added most to China Biologic Products Holdings, Inc. in Q1 2020, an estimated $4.64M increase.
  • Kite Lake Capital Management (UK) fully exited Qiagen in Q1 2020, selling an estimated $6.65M.
  • Kite Lake Capital Management (UK)'s ten largest holdings make up 100% of its $62.7M portfolio in Q1 2020.
  • Kite Lake Capital Management (UK) opened 5 new positions and closed 1 in Q1 2020.
  • Kite Lake Capital Management (UK)'s portfolio value rose 99% quarter-over-quarter to $62.7M.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q1 2020, filed 15 May 2020.